STAND.
COM. REP. NO. 441
Honolulu, Hawaii
, 2019
RE: H.B. No. 654
H.D. 1
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirtieth State Legislature
Regular Session of 2019
State of Hawaii
Sir:
Your Committees on Lower & Higher Education and Health, to which was referred H.B. No. 654 entitled:
"A BILL FOR AN ACT RELATING TO HEALTH,"
beg leave to report as follows:
The Department of Health, University of Hawaii Cancer Center, American Cancer Society Cancer Action Network, O‘ahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i, and many individuals supported this measure.
Your Committees have amended this measure by:
(1) Changing the amounts appropriated in this measure to an unspecified amount;
(2) Changing its effective date to July 1, 2050, to encourage further discussion; and
(3) Making technical, nonsubstantive amendments for clarity, consistency, and style.
Should the Committee on Finance deliberate this measure further, your Committees on Lower & Higher Education and Health respectfully request that it consider appropriating $340,000 for fiscal year 2019-2020 and $380,000 for fiscal year 2020-2021 to the University of Hawaii Cancer Center to determine whether Hawaii has the highest incidence in the country of liver and bile duct cancer due to liver fluke infection, aflatoxin ingestion, or intrahepatic bile duct dilation.
As affirmed by the records of votes of the members of your Committees on Lower & Higher Education and Health that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 654, as amended herein, and recommend that it pass Second Reading in the form attached hereto as H.B. No. 654, H.D. 1, and be referred to your Committee on Finance.
Respectfully submitted on behalf of the members of the Committees on Lower & Higher Education and Health,
|
____________________________ JOHN M. MIZUNO, Chair |
|
____________________________ JUSTIN H. WOODSON, Chair |
|
|
|
|